In this study, we demonstrated the synergistic inhibitory effects on murine melanoma cell line B16-F10 and human melanoma cell line SK-MEL-2-Luc under simultaneous and sequential combined treatments of VPA and ETO. This evidence concerns the gene RUNX1T1 and melanoma.